脑部放疗,上午比下午敏感许多!" o8 b: {# x* j: A# B- U0 F* w1 H! y
9 k+ _: w) y" _9 H: E/ m3 `$ p: b
! F$ l0 r1 j6 M- Z% F' t# ~$ X' e1 |- dCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.8 J7 _% e6 o3 N. A3 m! t3 B0 l
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
9 u/ j* y$ |; f. G* s9 bRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.7 Q3 [8 V |8 v! G5 W2 b+ C
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
5 y9 k$ A- f/ ^( a6 [- v
7 B" h; N9 x4 v1 OAbstract
- A" }* [+ B; kBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
, }. q" s8 ^3 [7 H7 b
, P1 Z d. M3 E q4 ^1 g" X' j+ j W4 CMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
/ @! U) c2 I! V" B9 u0 B7 ]/ L3 L9 I) u9 W6 ?+ N0 ^/ C9 u
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).' y4 A& f! `1 t6 U$ C
% H6 K6 f' p5 v/ t" d0 m' L+ }- jCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
$ R' R, Y9 B- ]# U6 Y' ` w! K% y4 O _0 Z u
|